If you’re looking into weight loss drugs, liraglutide has no doubt popped up. It’s a diabetes and weight loss medication sold ...

As of March 24, 2025, both the FDA and the American Society of Health-System Pharmacists (ASHP) websites have listed branded ...

Victoza is competing against several other companies in the GLP-1 market, including AstraZeneca's Bydureon, which has a patient-friendly weekly injection ... has become the first drug recommended ...

Previous research indicates that liraglutide, a lesser-know weight-loss injection that's manufactured by Novo Nordisk under the brand names Saxenda and Victoza, can slow down ... speak with your ...

Liraglutide is on the market as Victoza for diabetes and Saxenda for ... Ozempic for diabetes and Wegovy for obesity – which can be dosed by injection once a week. Novo Nordisk is already ...

Your doctor or pharmacist can show you how to do this when you first start treatment. Ozempic injections are given ... type 2 diabetes and heart disease Victoza can also be used to help manage ...

It announced it would make GLP-1 injections available to its customers ... Ozempic and Wegovy, the first big names in this new era, used a GLP-1RA known as semaglutide. As we know, these drugs ...

Still, the more recent growth of these drugs has a lot of investors very optimistic, and there are other opportunities in this market beyond injections ... are not the first GLP-1 drugs to hit ...

More recent ones include: A 2017 $59 million fine from the DOJ due to lack of FDA disclosures concerning cancer risks from diabetes drug Victoza Membership ... via injection, rather than in ...

Another difference between Victoza and Ozempic is the frequency of injections. This is because Victoza is eliminated ... They are not commonly used for first-line treatment unless you are at high risk ...